These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30136773)

  • 1. Corporatisation of Community Pharmacy and the Constitutional Prohibition of Civil Conscription for Medical Service Providers.
    Yazidjoglou C; Faunce T
    J Law Med; 2016; 24(1):41-60. PubMed ID: 30136773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The regulation of pharmacy ownership in Australia: the potential impact of changes to the health landscape.
    Hattingh HL
    J Law Med; 2011 Sep; 19(1):147-54. PubMed ID: 21988016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selim v Lele and the civil (industrial) conscription prohibition: constitutional protection against federal legislation controlling or privatising Australian public hospitals.
    Faunce T
    J Law Med; 2008 Aug; 16(1):36-48. PubMed ID: 18807793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutional limits on federal legislation practically compelling medical employment: Wong v Commonwealth; Selim v Professional Services Review Committee.
    Faunce T
    J Law Med; 2009 Oct; 17(2):196-205. PubMed ID: 19998589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the impact of evolving health policy on independent pharmacy ownership in England.
    Gidman W
    Pharm World Sci; 2010 Aug; 32(4):488-95. PubMed ID: 20454857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a mental health medication management intervention in Australian community pharmacies: Facilitators and challenges.
    Hattingh HL; Kelly F; Fowler J; Wheeler AJ
    Res Social Adm Pharm; 2017; 13(5):969-979. PubMed ID: 28583302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy's claims to professional status in the United Kingdom.
    Bush J; Langley CA; Wilson KA
    Res Social Adm Pharm; 2009 Dec; 5(4):305-18. PubMed ID: 19962674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse practitioners: an insight into their integration into Australian community pharmacies.
    McMillan SS; Emmerton L
    Res Social Adm Pharm; 2013; 9(6):975-80. PubMed ID: 23062783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing pharmacy services in opioid substitution treatment.
    Chaar BB; Wang H; Day CA; Hanrahan JR; Winstock AR; Fois R
    Drug Alcohol Rev; 2013 Jul; 32(4):426-34. PubMed ID: 23442133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stakeholders' expectations and perceived effects of the pharmacy ownership liberalization reform in Sweden: a qualitative interview study.
    Wisell K; Winblad U; Sporrong SK
    BMC Health Serv Res; 2016 Aug; 16(1):379. PubMed ID: 27519573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Providing patient care in community pharmacies in Australia.
    Benrimoj SI; Roberts AS
    Ann Pharmacother; 2005 Nov; 39(11):1911-7. PubMed ID: 16219897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promoting weight management services in community pharmacy: perspectives of the pharmacy team in Scotland.
    Weidmann AE; MacLure K; Marshall S; Gray G; Stewart D
    Int J Clin Pharm; 2015 Aug; 37(4):599-606. PubMed ID: 25822039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2017 deregulation of pharmacies in Italy: Introducing non-pharmacist ownership.
    Gallone EL; Ravetto Enri L; Pignata I; Baratta F; Brusa P
    Health Policy; 2020 Dec; 124(12):1281-1286. PubMed ID: 32994057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of chronic disease management algorithms in Australian community pharmacies.
    Morrissey H; Ball P; Jackson D; Pilloto L; Nielsen S
    Res Social Adm Pharm; 2015; 11(2):176-96. PubMed ID: 25035062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.
    Lee RY; Moles R; Chaar B
    Contraception; 2015 Jan; 91(1):25-30. PubMed ID: 25248673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community pharmacy in Australia.
    Benrimoj SI; Frommer MS
    Aust Health Rev; 2004 Nov; 28(2):238-46. PubMed ID: 15527404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provision of primary care to patients with chronic cough in the community pharmacy setting.
    Schneider CR; Everett AW; Geelhoed E; Kendall PA; Murray K; Garnett P; Salama M; Clifford RM
    Ann Pharmacother; 2011 Mar; 45(3):402-8. PubMed ID: 21325099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacy practice developments: the potential impact on pharmacists' legal liability.
    Hattingh L; Forrester K; Smith N; Searle J
    J Law Med; 2007 Feb; 14(3):397-402. PubMed ID: 17355101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.